NASDAQ:IMRX | Insider Transactions — Page 2 | Immuneering Corp

IMRX Insider Transactions — Page 2

117 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–117; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Feinberg PeterDirector2021-09-13Purchase5,750.0$21.51
Zeskind Benjamin J.PRESIDENT AND CEO2021-09-13Purchase2,083.0$22.87
Cormorant Asset Management, LPOther2021-08-03Purchase550,000.0$15.0
Chen BihuaTenPercentOwner2021-08-03Purchase550,000.0$15.0
Cormorant Global Healthcare Master Fund, LPTenPercentOwner2021-08-03Purchase550,000.0$15.0
Cormorant Private Healthcare Fund III LPTenPercentOwner2021-08-03Purchase550,000.0$15.0
Feinberg PeterDirector2021-08-03Purchase33,333.0$15.0
Feinberg PeterDirector2021-08-03Purchase129,167.0$15.0
Feinberg PeterDirector2021-08-03Purchase129,167.0$15.0
Zeskind Benjamin J.President and CEO2021-08-03Purchase2,098.0$15.0
KEATING LAURIEDirector2021-08-03Purchase7,000.0$15.0
Hall Brett MatthewChief Scientific Officer2021-08-03Purchase1,353.0$15.0
CARPENTER ROBERT JDirector2021-08-03Purchase325,000.0$15.0
Bookman MichaelGeneral Counsel and Secretary2021-08-03Purchase1,402.0$15.0
BERMAN ANN EDirector2021-08-03Purchase3,500.0$15.0
Barrett ScottChief Medical Officer2021-08-03Purchase667.0$15.0
Amin BirenCFO, Treasurer2021-08-03Purchase4,175.0$15.0